Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-03-28
2006-03-28
Jones, Dwayne (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S557000
Reexamination Certificate
active
07019032
ABSTRACT:
An agent for preventing and/or treating Parkinson's disease or Parkinson's syndrome, comprising, as an active ingredient, an astrocyte function-improving agent is disclosed. The astrocyte function-improving agent is preferably a compound represented by formula (I), a non-toxic salt thereof, or a hydrate thereof:R5, R6, R11and n are defined in the specification.
REFERENCES:
patent: 5240662 (1993-08-01), Erdos et al.
patent: 5672746 (1997-09-01), Nau et al.
patent: RE37670 (2002-04-01), Nau et al.
patent: 0 632 008 (1995-01-01), None
patent: 0 632 008 (1995-01-01), None
patent: 632008 (1994-05-01), None
patent: 07 316092 (1995-12-01), None
patent: 2 076 700 (1997-04-01), None
DiPiro et al., Editor-in-Chief, Pharmacotherapy, A Pathophysiologic Approach, Chapter 42, Parkinson's Disease, pp. 632-641, 1989.
Stedman's Medical Dictionary, 25thEdition, Illustrated, pp. 1256, 1268 1994.
Webster's II, New Riverside University Dictionary, p. 933, 1988.
M. Kohutnicka, et al, “Microglial and Astrocytic Involvement in a Murine Model of Parkinson's Disease Induced by 1-Methyl-4-Phenyl,-1,2,3,6-Tetrahydropyridine (MPTP),”Immunopharmacology, Elsevier Science Publishers BV, XX, vol. 39, No. 3, 1998, pp. 167-180.
B. Mirza, et al, “The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease,” Database Embase 'Online!, Elsevier Science Publishers, XP002182465, Abstract, & Neuroscience, (1999) 95/2, (425-432).
D. L. Montgomery, “Astrocytes: form, functions, and roles in disease,” Database Medline 'Online!, U.S. national Library of Medicine (NLM), Bethesda, MD, XP002182466, Abstract, & Veterinary Pathology, (Mar. 1994) 31 (2), 145-67.
Patent Abstracts of Japan, JP 07-316092, date Dec. 5, 1995.
XP-002182465—Abstract (1999).
XP-002182466—Abstract (/1994).
Malgorzata Kohutnicka et al., Microglial and Astrocyctic Involvement in a Murine Model of Parkinson's Disease Induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), (1998), pp. 167-180.
Araki Tsutomu
Itoyama Yasuto
Kato Hiroyuki
Jones Dwayne
Ono Pharmaceutical Co. Ltd.
LandOfFree
Agent for treating Parkinson's disease comprising astrocyte... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for treating Parkinson's disease comprising astrocyte..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for treating Parkinson's disease comprising astrocyte... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3578697